Stanley Druckenmiller Bicycle Therapeutics PLC Transaction History
Duquesne Family Office LLC
- $4.39 Billion
- Q1 2024
A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Duquesne Family Office LLC holds 190,200 shares of BCYC stock, worth $3.85 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
190,200Holding current value
$3.85 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
99Shares Held
30.6MCall Options Held
85.5KPut Options Held
11.6K-
Baker Bros. Advisors LP New York, NY4.94MShares$100 Million1.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$70.6 Million2.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.25MShares$65.7 Million3.03% of portfolio
-
Armistice Capital, LLC New York, NY1.67MShares$33.8 Million0.57% of portfolio
-
Tybourne Capital Management (Hk) LTD Hong Kong, K31.55MShares$31.3 Million8.61% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $601M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...